Research Topics
| Sanjit S JollySummaryAffiliation: McMaster University Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly
McMaster University and the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada
Am Heart J 161:254-260.e1-4. 2011..Radial access versus femoral access has yet to be formally evaluated in a randomized trial adequately powered for the comparison of clinically important outcomes...
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trialsSanjit S Jolly
Department of Medicine, Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada
Am Heart J 157:132-40. 2009..The objective of this meta-analysis was to determine if radial access reduces major bleeding and as a result can reduce death and ischemic events compared to femoral access...
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) triaSanjit S Jolly
Department of Medicine, Hamilton Health Sciences, Population Health Research Institute, McMaster University, McMaster Clinic Room 630, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada
J Am Coll Cardiol 54:468-76. 2009..This study sought to evaluate the relative safety and efficacy of fondaparinux and enoxaparin in patients with acute coronary syndromes (ACS) treated with glycoprotein (GP) IIb/IIIa inhibitors or thienopyridines...
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly
Population Health Research Institute, Department of Medicine, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
Heart 97:197-202. 2011..The objective of this study was to determine if the extent of quantitative troponin elevation predicted mortality as well as in-hospital complications of cardiac arrest, new heart failure and cardiogenic shock...
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialSanjit S Jolly
McMaster University and the Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada
Lancet 377:1409-20. 2011..We aimed to assess whether radial access was superior to femoral access in patients with acute coronary syndromes (ACS) who were undergoing coronary angiography with possible intervention...
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevationShamir R Mehta
McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada
J Am Coll Cardiol 60:2490-9. 2012....
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trialSanjit S Jolly
Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada
JACC Cardiovasc Interv 6:258-66. 2013..The authors sought to compare the radiation dose between radial and femoral access...
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta
McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada
Lancet 376:1233-43. 2010..We assessed the effect of various clopidogrel and aspirin regimens in prevention of major cardiovascular events and stent thrombosis in patients undergoing PCI...
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta
Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
N Engl J Med 360:2165-75. 2009..Earlier trials have shown that a routine invasive strategy improves outcomes in patients with acute coronary syndromes without ST-segment elevation. However, the optimal timing of such intervention remains uncertain...
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE studySanjit S Jolly
Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada
Eur Heart J 30:900-7. 2009..In the setting of percutaneous coronary intervention (PCI), due to a paucity of data, the optimal dose of aspirin is uncertain. We evaluated the safety of different doses of aspirin after PCI...
Angiographic and clinical outcomes after implantation of drug eluting stents in bifurcation lesions with crush or kissing stent techniqueAsim N Cheema
Terrence Donnelly Heart Center, Division of Cardiology, St Michael s Hospital, Toronto, Ontario, Canada
J Interv Cardiol 26:145-52. 2013..In this study, we report 6-9-month angiographic follow-up and long-term clinical outcomes after implantation of drug-eluting stents by crush and kissing stent technique for coronary bifurcation lesions...
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoringMelissa Rousseau
Division of Cardiology, St Michael s Hospital, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada
Am J Cardiol 106:1417-22. 2010..This suggests that anemia might predispose patients to recurrent ischemia, which could be an important underlying mediator of worse outcomes in patients with lower hemoglobin levels...
Characterization of operator learning curve for transradial coronary interventionsWarren T Ball
Terrence Donnelly Heart Center, St Michael s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, Canada
Circ Cardiovasc Interv 4:336-41. 2011..Transradial percutaneous coronary intervention (TR-PCI) improves clinical outcomes compared to the transfemoral (TF) approach. However, inadequate training and experience has limited widespread adoption by interventional cardiologists...
Left main thrombus as a complication of thrombectomy during primary percutaneous coronary interventionAshraf Alazzoni
Hamilton Health Sciences, McMaster University Medicine, DBCVSRI Building Rm C3 118, 237 Barton St East, Hamilton General Hospital, Hamilton, Ontario, L8L 2X2, Canada
J Invasive Cardiol 23:E9-11. 2011..We report a case of a device complication involving the left main coronary artery where a large burden of thrombus was brought back into the left main coronary artery from the circumflex during aspiration thrombectomy...
An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomyJuan J Russo
University of Toronto, Toronto, Ontario, Canada
EuroIntervention 8:1143-8. 2013..We sought to evaluate practices during PPCI for ST-elevation myocardial infarction (STEMI), including the use of aspiration thrombectomy, and to determine the feasibility of conducting a definitive aspiration thrombectomy trial...
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized TrialsAshraf Alazzoni
Departments of Medine and Cardiology, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada L8L 2X2
Thrombosis 2012:126369. 2012..Interpretation. Everolimus compared to paclitaxel-eluting stents reduced the incidence of early, late, and very late stent thrombosis as well as target vessel revascularization...
